Hints and tips:
Related Special Reports
...“The problem is not infinite,” says Dr John Mascola, director of the vaccine research centre at the National Institute of Allergy and Infectious Diseases, an agency of the US Department of Health....
...at critics who have accused vaccine makers of not doing enough to support rollouts in developing countries such as South Africa, where only a quarter of the population is fully inoculated, according to Johns...
...“The stimulus was the tragedy that we had a near 100 per cent effective vaccine that languished in development for more than a decade and arrived too late to prevent the damage,” says Richard Hatchett, chief...
...“All these timelines are aggressive and aspirational,” said Dr Hatchett....
...Tom Geldard, head of digital, and Mike Hatchett, director of policy, also attend....
...“This is known as ‘conditional indexation’ and could be a way to create the breathing space for businesses being pulled down by struggling pension schemes,” said Jon Hatchett, head of corporate consulting...
...“The thing that is most interesting is that it has taken Tesco so long to fully close its DB scheme,” said John Ralfe, an independent pensions consultant....
...“There continues to be a tension between financial constraints and new initiatives to reward and engage employees,” said Alastair Hatchett, head of pay services at IDS....
International Edition